1. Clinical Significance of HMGB1 Expression in Human Gastric Cancer
    J. Zhang et al, 2014, International Journal of Immunopathology and Pharmacology CrossRef
  2. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products
    Yan Chen et al, 2015, PLOS ONE CrossRef

  3. A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer


    Tuo Ruan et al, 2020, OncoTargets and Therapy CrossRef
  4. High-mobility group box 1 is a promising diagnostic and therapeutic monitoring biomarker in Cancers: A review
    Seidu A. Richard et al, 2018, AIMS Molecular Science CrossRef
  5. The prevention of multi-drug resistance in cancers through the application of nanotechnology-based targeted delivery systems for combination therapies involving traditional Chinese medicine
    Salik Abdullah et al, 2024, Pharmacological Research - Modern Chinese Medicine CrossRef
  6. NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance
    Meng Zhang et al, 2020, Frontiers in Oncology CrossRef
  7. Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway
    Yun Xiao et al, 2019, Cell Division CrossRef
  8. Molecular and cellular paradigms of multidrug resistance in cancer
    Foram U. Vaidya et al, 2022, Cancer Reports CrossRef
  9. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma
    Qingbing Meng et al, 2014, Tumor Biology CrossRef
  10. HMGB1 and repair: focus on the heart
    Laura Pellegrini et al, 2019, Pharmacology & Therapeutics CrossRef
  11. Multiple functions of HMGB1 in cancer
    Guangyao Lv et al, 2024, Frontiers in Oncology CrossRef
  12. Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
    Weixin Lai et al, 2021, Cancer Cell International CrossRef
  13. Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance
    Kazem Nejati et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
  14. Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells
    Shengnan Guo et al, 2016, Medical Science Monitor CrossRef
  15. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer
    P. S. Thakur et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
  16. Erythropoietin as Potential Neuroprotective and Antiepileptogenic Agent in Epilepsy and Refractory Epilepsy
    Amalia Marelli et al, 2016, Antiepileptic Drug Discovery CrossRef